NCT02094326View on ClinicalTrials.gov

Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)

CompletedOBSERVATIONAL

Enrollment

301

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Rheumatoid Arthritis

Trial Locations (11)

18014

Consulta privada Dr. Rafael Cáliz, Granada

29004

Hospital Quirón Málaga, Málaga

29630

Clinica Xanit, Málaga

41071

Hospital Virgen Macarena, Seville

Unknown

Hospital Reina Sofía, Córdoba

Hospital San Cecilio, Granada

Hospital Virgen de las Nieves, Granada

Consulta Dra. Belmonte, Málaga

Hospital Carlos Haya, Málaga

Hospital Virgen del Rocío, Seville

Hospital Comarcal de Melilla, Melilla

All Listed Sponsors

lead

Fundación Andaluza de Reumatología

OTHER

NCT02094326 - Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA) | Biotech Hunter | Biotech Hunter